FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileMyrexis, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MYRX
Myrexis, Inc. Stock AnalysisComprehensive stock analysis for Myrexis, Inc. (MYRX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMYRX
MYRX
Myrexis, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MYRX
Home🔹Stocks🔹Myrexis, Inc.

Myrexis, Inc.

🇺🇸MYRX•OTC

Myrexis, Inc.

🇺🇸MYRX•OTC
Market cap
$17.24K
Sentiment

Your view on MYRX

Mkt Cap
$17.24K
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Myrexis, Inc.

Industry
Shell Companies
Sector
Financial Services
CEO
Jonathan Couchman
Headquarters
630 Fifth Avenue, New York City, NY, US
Industry
Shell Companies
Sector
Financial Services
CEO
Jonathan Couchman
Headquarters
630 Fifth Avenue, New York City, NY, US
Description

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

Fair value for Myrexis, Inc. from FRC's valuation model, read against the market price. MYRX last traded at $0.0005; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Myrexis, Inc.. Starting points for Myrexis, Inc.: EPS -$0.39, beta 3.96 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Myrexis, Inc.. Myrexis, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Myrexis, Inc.. Trailing twelve-month EPS for Myrexis, Inc. stands at -$0.39. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

As of Nov 12, 2026 · USD

Earnings Estimate

EPSCurrent QtrJun 2021Next QtrSep 2021
Avg. estimate$1.01$1.25
Low estimate$1.01$1.25
High estimate$1.01$1.25
No. of analysts11
Year-ago EPS——
Growth——

Revenue Estimate

RevenueCurrent QtrJun 2021Next QtrSep 2021
Avg. estimate$0.00$0.00
Low estimate$0.00$0.00
High estimate$0.00$0.00
No. of analysts00
Year-ago revenue——
Growth——

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Myrexis, Inc.. Myrexis, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Myrexis, Inc. valued side by side against its closest peers. Myrexis, Inc. is measured against Shell Companies peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Insider Trading

Recent buying and selling by company executives.

Buying and selling by Myrexis, Inc. executives and directors. Shares of Myrexis, Inc. have traded between $0.0001 and $0.0070 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Myrexis, Inc.. Coverage tracks Myrexis, Inc. within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Myrexis, Inc.

Peer companies

  • AAPTAll American Pet Company, Inc.
  • ALDAAtlantica, Inc.
  • CDSGChina Dongsheng International, Inc.
  • CNHCChina Health Management Corp.
  • JADAJade Art Group Inc.
  • LTUSLotus Pharmaceuticals, Inc.
  • OOGIC2E Energy, Inc.
  • OWVIOne World Ventures, Inc.

More Shell Companies companies

  • ARBUAmerican Business Corp.
  • ARCIArchimedes Tech SPAC Partners III Co.
  • ARCIUArchimedes Tech SPAC Partners III Co. Units
  • ARCLARC Group Acquisition I Corp Class A Ordinary Shares
  • ARCLRARC Group Acquisition I Corp Right
  • ARCLUARC Group Acquisition I Corp Unit
  • ARCLWARC Group Acquisition I Corp Warrants
  • ARTCUArt Technology Acquisition Corp. Units
  • ASCBFA SPAC II Acquisition Corp.
  • ASPCA SPAC III Acquisition Corp.
  • ASPCRA SPAC III Acquisition Corp.
  • ASPCUA SPAC III Acquisition Corp.
MYRX Analysis
Fair
Past5
Growth1
Health5
Profit1
Value1

News

Latest Market News